A single-dose multicomponent mRNA vaccine elicits durable immune responses against influenza and COVID-19 in a Phase 1/2 ...

The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and ...

Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.

In an experimental trial, a personalized mRNA vaccine was tested in 14 individuals with an aggressive form of breast cancer. It trained immune cells to target cancer-specific mutant proteins, inducing ...

An individualized neoantigen mRNA vaccine was tested in patients with early-stage triple-negative breast cancer and showed ...

The study involved 550 healthy U.S. adults ages 18 to 75 who received either the experimental combo vaccine and a placebo or ...

From a potential new flu vaccine to a groundbreaking surgical first and critical health reminders, here's today's essential health news.